MrMed operates an online super-specialty pharmacy focused on timely access to affordable medicines for conditions such as kidney disease, heart disorders, cancer, HIV/AIDS, and transplants. The company was co-founded by Devashish Singh and Saurab Jain in 2021. Since launching, MrMed says it has served over 50,000 users across 2,000 cities in India and recorded an annual recurring revenue of over ₹26 crore as of July 2023. The platform aims to build a profitable yet scalable brand in the super-specialty healthcare space while maintaining customer service and operational excellence. Recent plans include using new capital for customer acquisition, marketing initiatives, team expansion, and exploring adjacent ventures within the pharma supply chain and healthcare service provider sectors.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2023